Teleflex Medical, Reseach Traingle Park, NC, has launched the Hybrid™, an interface for use with therapy systems designed to treat obstructive sleep apnea (OSA). The Hybrid interface combines a nasal interface with and oral interface to create a product that can serve as either or both at the same time. Its propriety design also enhances patient comfort and compliance by eliminating pressure points on the forehead and across the bridge of the nose.

“We at Teleflex Medical are excited to bring this innovative technology to market.  The proprietary design of the Hybrid redefines the management of obstructive sleep apnea by providing optimal patient comfort resulting in greater therapy compliance,” said Tim Hopper, VP/general manager of the Medical Products Business Unit, Teleflex Medical.  “As a result, the Hybrid will transform the way OSA management is viewed moving forward.”